As reviewed by Mikhailov and Torrado, NRF2 expression is increased during early stages of cardiac hypertrophy but decreased at mild pathological hypertrophy (commonly associated with HFpEF) [20]. The gene discussed is NFE2L2; the disease is cardiac hypertrophy.